On the other hand, niclosamide suppressed the LRP6 expression in TNBC MDA-MB-231 cells and ER-positive breast cancer T-47D cells and inhibited breast cancer cell proliferation with IC50 values less than 1 mM [25]. Here, LRP6 is linked to breast carcinoma.